The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure

Biochimie

Volumn 81, Issue 10, 1999, Pages 955-963

  Volpi, Nicola ^a   Tarugi, Patrizia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chondroitin; Dermatan; Heparan; Heparin; Low density lipoprotein

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); ALKADIENE; ANTIOXIDANT; CHONDROITIN SULFATE; COPPER ION; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN; 2,2'-AZOBIS(2-AMIDINOPROPANE); AMIDINE; COPPER;

ARTICLE; CARBOHYDRATE ANALYSIS; CATTLE; CHEMICAL REACTION KINETICS; HUMAN; HUMAN TISSUE; KIDNEY; NORMAL HUMAN; OXIDATION; SPLEEN; TRACHEA; ANIMAL; CHEMISTRY; IN VITRO STUDY; KINETICS; METABOLISM; OXIDATION REDUCTION REACTION; SPECTROFLUOROMETRY; STRUCTURE ACTIVITY RELATION; SWINE;

BOS TAURUS;

AMIDINES; ANIMALS; CATTLE; CHONDROITIN SULFATES; COPPER; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; HEPARIN; HEPARITIN SULFATE; HUMANS; KINETICS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

EID: 0032586076     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)00224-2     Document Type: Article

References (30)

1. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.
2. Berliner J.A., Haberland M.E. The role of oxidized LDL in atherogenesis. Curr. Opin. Lipid. 4:1993;373-381.
3. Liu S.X., Zhou M., Chen Y., Wen W.Y., Sun M.J. Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation. Atherosclerosis. 121:1996;55-61.
4. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8:1994;1279-1284.
5. Parthasarathy S., Young S., Witzum J.L., Pittman R.C., Steinberg D.L. Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77:1986;641-644.
6. Camejo G., Hurt-Camejo E., Rosengren B., Wiklund O., Lopez F., Bondjers G. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J. Lipid Res. 32:1991;1983-1991.
7. Hollimann J., Schmidt A., von Bassewitz D.B., Buddecke E. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis. 9:1989;154-158.
8. 2+-mediated oxidation of human low-density lipoproteins. FEBS Lett. 377:1995;240-242.
9. 2+-mediated LDL oxidation. FEBS Lett. 403:1997;154-158.
10. 2+-mediated oxidation of human low-density lipoproteins. Effect of normal human plasma-derived chondroitin sulfate. J. Biochem. Tokyo. 125:1999;297-304.
11. Gigli M., Ghiselli G., Torri G., Naggi A., Rizzo V. A comparative study of low-density lipoprotein interaction with glycosaminoglycans. Biochim. Biophys. Acta. 1167:1993;211-217.
12. Christner J.E., Baker J.R. A competitive assay of lipoprotein: proteoglycan interaction using a 96-well microtitration plate. Anal. Biochem. 184:1990;388-394.
13. Crescenzi V., Dea I.C.M., Paoletti S., Stivala S.S., Sutherland I.W. (Eds.). Biomedical and biotechnological advances in industrial polysaccharides. 1989;Gordon and Breach Sci. Publ., New York.
14. Yu B.P. Cellular defenses against damage from reactive oxygen intermediates. Physiol. Rev. 74:1994;139-160.
15. Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:1992;901-905.
16. Puhl H., Waeg G., Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 233:1994;425-441.
17. Volpi N. Inhibition of human leukocyte elastase activity by heparins: influence of charge density. Biochim. Biophys. Acta. 1290:1996;299-307.
18. Volpi N. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture. Anal. Biochem. 218:1994;382-391.
19. Poblacion C.A., Michelacci Y.M. Structural differences of dermatan sulfates from different origins. Carbohydr. Res. 147:1986;87-100.
20. Volpi N., Fregni R., Venturelli T. Activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment. J. Chrom. B Biomed. Appl. 669:1995;197-205.
21. Shaklee P.N., Conrad H.E. The disaccharides formed by deaminative cleavage of N-deacetylated glycosaminoglycans. Biochem. J. 235:1986;225-236.
22. Volpi N., Bolognani L. Glycosaminoglycans and proteins: different behaviours in high-performance size-exclusion chromatography. J. Chromatogr. 630:1993;390-396.
23. Chapman M.J., Goldstein S., Lagrange D., Laplaud P.M. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid. Res. 22:1981;339-358.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol method. J. Biol. Chem. 193:1951;265-275.
25. Jackson R.J., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:1991;481-539.
26. Niki E. Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol. 186:1990;100-108.
27. Nieduszynski I. General physical properties of heparin. Lane D.A, Lindahl U. Heparin. Chemical and Biological properties. Clinical applications. 1989;51-63 ward Arnold, London, Melbourne, Auckland.
28. Ross M.A., Long W.F., Williamson F.B. Inhibition by heparin of Fe-catalyzed free radical peroxidation of linolenic acid. Biochem. J. 286:1992;717-720.
29. Giessauf A., Steiner E., Esterbauer H. Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL. Biochim. Biophys. Acta. 1256:1995;221-232.
30. Kuzuya M., Yamada K., Hayashi T., Funaki C., Naito M., Asai K., Kuzuya F. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim. Biophys. Acta. 1123:1992;334-341.